DNALYTICS
Company Snapshot
Founded: 2012
Entity Type: Private
Region: Belgium
Headquarter: Louvain-la-Neuve, Wallonia, Belgium
Key Geographics: Belgium
Corporate Address: Centre Monnet – Avenue Jean Monnet, 1348 Louvain-la-Neuve, Wallonia Belgium Tel. www.dnalytics.com
Company Overview
DNAlytics, founded in 2012 as a spinoff of UCLouvain, is developing and commercializing assays for screening and patient monitoring in cancer and rheumatology.
The company’s lead liquid biopsy product is ColonoKit, a noninvasive colorectal cancer screening test in joint development with VIB. The test is based on a 23-gene expression signature in tumor educated circulating monocytes that was identified by VIB. The test can be used before colonoscopy to detect the presence of colorectal cancer.
Company's Business Segments
- Healthcare Services : Data Mining, Statistics, Personalized Medicine, Clinical Trials, Diagnostic, Prognostic, Theranostic, Biomarkers
Applications/End User Industries
- Healthcare
- Hospitals
- Diagnostics
- Theranostics